GLOW 70MG

What is GLOW 70MG?

GLOW 70 MG is a research‐grade synergistic peptide blend designed to support multi‐pathway investigations into tissue repair, cellular regeneration, anti-inflammatory signalling and extracellular matrix remodelling. According to supplier listings, the blend typically contains approximately 50 mg of GHK‑Cu (copper peptide), 10 mg of BPC‑157 and 10 mg of TB‑500 (Thymosin β4 fragment).
The blend is intended for laboratory research use only and is not approved for human or veterinary use.

Chemical Structure of GLOW 70MG

Because GLOW is a composite of three distinct peptides, its “chemical structure” is described via the components:

• GHK-Cu: a tripeptide complex of glycyl-L-histidyl-L-lysine bound to copper(II) ions.

• BPC-157: a synthetic peptide derived from body protection compound region (sequence often reported as “Gly-His-Lys…” etc).

• TB-500: a fragment of Thymosin β4 (specifically amino acids 17-34 in some listings) used for tissue repair research.
  The blend is supplied as a lyophilized powder (70 mg total mass) in a sterile vial, typically >98-99% purity by HPLC according to supplier claims.
  Because the blend combines multiple peptides, there is no single molecular formula or molecular weight other than the total mass of the preparation.

What Are the Effects of GLOW 70MG?

In research contexts, GLOW is used to explore combined effects of its constituent peptides:

• Tissue repair & regeneration: TB-500 and BPC-157 have been widely studied in preclinical models for promoting fibroblast migration, angiogenesis, tendon and muscle repair, and cellular regeneration.

• Extracellular matrix & skin remodelling: GHK-Cu is known for modulating gene expression linked to collagen synthesis, elastin production and skin repair pathways, making it of interest for dermal and musculoskeletal research.

• Anti-inflammatory and oxidative stress modulation: The combination of the peptides is marketed for research into inflammation reduction, oxidative damage mitigation and overall cellular renewal.
  Because this is a research blend, claims about effects remain exploratory and preclinical in nature.

Research-Use Disclaimer:

This product is supplied solely for in vitro and/or research use only. It is not intended for human or veterinary administration. The effects described are drawn from supplier listings and preclinical research; they are not approved clinical claims.